<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Clinical effectiveness of bone marrow transplantation has been analyzed in 83 patients with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Bone marrow of non-related donors with high degree of histocompatibility, according to the antigen system HLA of loci A, B, C and DR, was used </plain></SENT>
<SENT sid="2" pm="."><plain>Freshly prepared bone marrow was transplanted in doses from 3.4 x 10(9) to 15 x 10(9) myelokaryocytes </plain></SENT>
<SENT sid="3" pm="."><plain>Immunosuppression was provided by <z:chebi fb="1" ids="36699">corticosteroid hormones</z:chebi> and antithymocytic globulin </plain></SENT>
<SENT sid="4" pm="."><plain>Complete or partial remission lasting for more than a year was recorded in 56 patients </plain></SENT>
<SENT sid="5" pm="."><plain>Formed elements of the donor's blood were detected in the blood of 39% of the patients (the observation period lasted from 1 to 8 months) </plain></SENT>
<SENT sid="6" pm="."><plain>Symptoms of a <z:e sem="disease" ids="C0277555" disease_type="Disease or Syndrome" abbrv="">secondary disease</z:e> were observed in 29% of the patients </plain></SENT>
<SENT sid="7" pm="."><plain>Significant changes in the cellular immunity parameters were recorded in <z:hpo ids='HP_0000001'>all</z:hpo> the patients investigated </plain></SENT>
<SENT sid="8" pm="."><plain>The character of the time course of these changes may serve as a prognostic factor of myelotherapy effectiveness </plain></SENT>
</text></document>